We noted a substantial increase in the production of pro-inflammatory markers like IFNγ (p = 0.0836), MCP-1 (p < 0.05), and Eotaxin (p < 0.05) in the COVID-19 positive patient sera from those with a smoking history compared to the non-smoking controls. This evidence concerns the gene CCL2 and COVID-19.